Lexicon Pharmaceuticals
LXRX
#6646
Rank
โ‚ฌ0.75 B
Marketcap
1,69ย โ‚ฌ
Share price
0.54%
Change (1 day)
25.41%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚ฌ52.85 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ41.46 Million. In 2025 the company made an earning of -โ‚ฌ45.46 Million, an increase over its 2024 earnings that were of -โ‚ฌ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ52.85 Million16.25%
2025 -โ‚ฌ45.46 Million-74.88%
2024 -โ‚ฌ0.19 Billion13.15%
2023 -โ‚ฌ0.16 Billion73.74%
2022 -โ‚ฌ92.05 Million16.16%
2021 -โ‚ฌ79.24 Million49.82%
2020 -โ‚ฌ52.89 Million-147.19%
2019 โ‚ฌ0.11 B-203.42%
2018 -โ‚ฌ0.11 Billion-15.31%
2017 -โ‚ฌ0.13 Billion0.2%
2016 -โ‚ฌ0.13 Billion2920.7%
2015 -โ‚ฌ4.23 Million-95.33%
2014 -โ‚ฌ90.62 Million-3.61%
2013 -โ‚ฌ94.02 Million-5.52%
2012 -โ‚ฌ99.51 Million-4.17%
2011 -โ‚ฌ0.11 Billion15.5%
2010 -โ‚ฌ89.91 Million8.36%
2009 -โ‚ฌ82.97 Million-4.81%
2008 -โ‚ฌ87.17 Million28.79%
2007 -โ‚ฌ67.68 Million35.71%
2006 -โ‚ฌ49.87 Million52.91%
2005 -โ‚ฌ32.62 Million-23.89%
2004 -โ‚ฌ42.85 Million-24.19%
2003 -โ‚ฌ56.52 Million-0.48%
2002 -โ‚ฌ56.79 Million44.12%
2001 -โ‚ฌ39.41 Million23.01%
2000 -โ‚ฌ32.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ7.13 B-13,024.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.00 B-1,927.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ5.13 B-9,404.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.41 Billion 631.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ54.99 M-199.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚ฌ71.68 M-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.99 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ39.42 M-171.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ14.92 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA